Collegium Pharmaceutical, Inc. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
Collegium Pharmaceutical, Inc. (COLL) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $88.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2017-08-09
- Collegium Pharmaceutical, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-06-30 was $39.00K, a 48.68% decline year-over-year.
- Collegium Pharmaceutical, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-03-31 was $49.00K, a 40.96% decline year-over-year.
- Collegium Pharmaceutical, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-12-31 was $58.00K, a 37.63% decline year-over-year.
- Collegium Pharmaceutical, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-09-30 was $67.00K, a 15.52% increase year-over-year.
- Collegium Pharmaceutical, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2016 was $284.00K, a 19.55% decline from fiscal 2015.
- Collegium Pharmaceutical, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $353.00K, a 95.03% increase from fiscal 2014.
- Collegium Pharmaceutical, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $181.00K, a 147.95% increase from fiscal 2013.
- Collegium Pharmaceutical, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2013 was $73.00K.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|---|---|---|
| 2017-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $88.00K 10-Q · filed 2017-08-09 | $146.00K derived: sum of 3 quarters · filed 2017-08-09 | $213.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | $49.00K 10-Q · filed 2017-05-10 | $107.00K derived: sum of 2 quarters · filed 2017-05-10 | $174.00K derived: sum of 3 quarters · filed 2017-05-10 | $250.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $125.00K derived: sum of 2 quarters · filed 2017-03-10 | $201.00K derived: sum of 3 quarters · filed 2017-08-09 | $284.00K 10-K · filed 2017-03-10 |
| 2016-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $143.00K derived: sum of 2 quarters · filed 2017-08-09 | $226.00K 10-Q · filed 2016-11-10 | $319.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $159.00K 10-Q · filed 2017-08-09 | $252.00K derived: sum of 3 quarters · filed 2017-08-09 | $310.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $83.00K 10-Q · filed 2017-05-10 | $176.00K derived: sum of 2 quarters · filed 2017-05-10 | $234.00K derived: sum of 3 quarters · filed 2017-05-10 | $335.00K derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $151.00K derived: sum of 2 quarters · filed 2017-03-10 | $252.00K derived: sum of 3 quarters · filed 2017-03-10 | $353.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $159.00K derived: sum of 2 quarters · filed 2016-11-10 | $260.00K 10-Q · filed 2016-11-10 | $395.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $202.00K 10-Q · filed 2016-08-11 | $337.00K derived: sum of 3 quarters · filed 2017-03-10 | $337.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $101.00K 10-Q · filed 2016-05-11 | $236.00K derived: sum of 2 quarters · filed 2017-03-10 | $236.00K derived: sum of 3 quarters · filed 2017-03-10 | $262.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $135.00K derived: sum of 2 quarters · filed 2017-03-10 | $161.00K derived: sum of 3 quarters · filed 2017-03-10 | $181.00K 10-K · filed 2017-03-10 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $26.00K derived: sum of 2 quarters · filed 2015-11-12 | $46.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $26.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-12 | $46.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $20.00K 10-Q/A · filed 2015-07-17 | |||
| 2013-12-31 | $73.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |